Form D · Pharmaceuticals

iVeena Delivery Systems, Inc.

Salt Lake City, X1 · CIK 0001639219

Offering snapshot reported Jul 8, 2020 · SEC filing

Reported sold
$2.13M
Offering amount: $2.46M
Investors reported
0
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
May 29, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 8, 2020Amendment$2,130,337No comparison0SEC filing
May 29, 2019InitialYet to sellNo comparison0SEC filing
Dec 4, 2017InitialYet to sellNo comparison0SEC filing
Dec 8, 2016InitialYet to sellNo comparison0SEC filing
May 1, 2015Initial$10,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06c
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-340604

Source: Form D, filed Jul 8, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Balamurali Ambati Director, Executive
Jayakrishna Ambati Director
Robert U Dempsey Director
Barry Hanover Director
James U Jensen Director
Greg Jones Director
David Robinson Director
Heffernan Ron Director
Gerald Simmons Director, Executive
Ned Weinshenker Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
391 Chipeta Way Suite I
Salt Lake City, X1, 84108